Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells in vitro by inhibition of nuclear factor-κB activity

Figure 1 Evaluation by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay of pancreatic cancer MIA-PaCa-2 cell viability after propofol pretreatment. A: Cells were either untreated or treated with 10-100 μmol/mL propofol for 72 h; B: Cells treated with 100 μmol/mL propofol for 24, 48, or 72 h. ^aP < 0.05 vs control group.